Core Insights - Wellgistics Health has announced a strategic collaboration with TheracosBio to enhance the affordability and accessibility of diabetes medications in the U.S. healthcare system [1] - The partnership utilizes Wellgistics Health's "maker-to-taker" platform, which connects manufacturers directly to pharmacies and patients, eliminating costly intermediaries [1] Company Overview - Wellgistics Health is recognized as a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment [1] - TheracosBio is the manufacturer of Brenzavvy® (bexagliflozin), a medication aimed at treating diabetes [1] Industry Impact - The collaboration aims to address the rising costs of diabetes medications, making them more accessible to patients [1] - By leveraging a direct pipeline model, the initiative seeks to streamline the distribution process within the healthcare system [1]